HUTCHMED Divests 45% Stake in Shanghai Hutchison Pharmaceuticals to GP Health Service Capital and Shanghai Pharmaceuticals Holding

Everstone Capital Acquires Controlling Stake in Softgel Healthcare

September 14, 2022

Pharmaceuticals

Everstone Capital has acquired a controlling (majority) stake in Softgel Healthcare Private Limited (SHPL), a Chennai-headquartered CDMO specializing in soft gelatin capsules and probiotics and part of the Madras Pharma Group. The investment will support SHPL's global expansion and capability development across pharmaceutical, nutraceutical and OTC markets, with Everstone partners joining the company's board.

Lakeside Holding Acquires Hupan Pharmaceutical (Hubei) to Enter Medical Logistics in China

November 11, 2024

Healthcare Services

Lakeside Holding Limited, through its wholly owned subsidiary Sichuan Hupan, entered into an equity transfer agreement to acquire Hupan Pharmaceutical (Hubei) Co., Ltd. for RMB 4.0 million (US$0.6 million). The acquisition is expected to add approximately US$7 million in annual revenue and expands Lakeside’s capabilities into China’s medical logistics sector.

SHS Invests in Develco Pharma

December 17, 2020

Pharmaceuticals

Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH is making a minority growth investment from its SHS V fund in Swiss-German specialty drug company Develco Pharma. Develco, headquartered in Pratteln, Switzerland with ~125 employees and production in Schopfheim, Germany, develops and manufactures orally administered prolonged-release medicines and will use the investment to broaden its pipeline and expand capabilities.

SHS Capital and LPs Invest ~€10M in Develco Pharma

October 7, 2024

Pharmaceuticals

SHS Capital, together with its limited partners and other existing shareholders, is investing approximately €10 million in Develco Pharma to expand manufacturing capacity and accelerate product development in response to exceptionally strong demand. Develco, a specialty pharma developer and manufacturer of modified-release formulations headquartered in Pratteln (DACH region), has been backed by SHS since 2020 and reports an order book exceeding 12 months of revenue.

Hikma Pharmaceuticals Acquires Custopharm from Water Street Healthcare Partners

September 27, 2021

Pharmaceuticals

Hikma Pharmaceuticals has agreed to acquire Custopharm Inc., a US-based generic sterile injectables company, from Water Street Healthcare Partners for an initial $375 million plus up to $50 million in contingent consideration. The acquisition adds Custopharm's 13 approved products, R&D capabilities and pipeline to Hikma's injectables franchise and is expected to be accretive to Hikma's Injectables operating margin.

PureHealth Acquires 60% Stake in Hellenic Healthcare Group

October 7, 2025

Healthcare Services

PureHealth Holding PJSC agreed to acquire a 60% stake in Hellenic Healthcare Group (HHG), valuing HHG at about USD 2.3 billion. The acquisition integrates HHG’s hospital and diagnostic-centre footprint in Greece and Cyprus into PureHealth’s global healthcare platform.